Paroxysmal Nocturnal Hemoglobinuria: Symptoms, Diagnosis, and Modern Treatment

Paroxysmal nocturnal hemoglobinuria (PNH) is a rare, acquired blood disorder in which red blood cells are destroyed prematurely by the body's complement system, a part of the immune system. This process, known as hemolysis, can lead to anemia, fatigue, blood clots, and other serious complications. Although PNH is a lifelong condition, advances in targeted therapies have significantly improved disease management and quality of life for many individuals. Early diagnosis, individualized treatment, and regular follow-up with a hematology specialist are essential for reducing complications and supporting long-term health.

What Is Paroxysmal Nocturnal Hemoglobinuria?

PNH develops because of a genetic change in blood-forming stem cells within the bone marrow.

As a result:

• Red blood cells become more vulnerable to destruction.
• Hemoglobin is released into the bloodstream.
• The risk of blood clots increases.
• Bone marrow function may also be affected.

PNH is not inherited and usually develops during adulthood, although it can occur at any age.

Common Symptoms

Symptoms vary depending on the severity of the disease and may include:

• Persistent fatigue
• Weakness
• Shortness of breath
• Dark or reddish urine, especially in the morning
• Pale skin
• Abdominal pain
• Difficulty swallowing
• Headaches
• Erectile dysfunction in some men
• Easy bruising or bleeding if bone marrow failure is present

Some individuals have mild symptoms, while others experience significant complications.

Potential Complications

Without appropriate treatment, PNH may lead to:

• Blood clots (thrombosis)
• Severe anemia
• Chronic kidney problems
• Pulmonary hypertension
• Bone marrow failure
• Reduced quality of life

Blood clots are among the most serious complications of PNH.

How Is PNH Diagnosed?

Diagnosis usually involves specialized laboratory testing.

A healthcare provider may recommend:

• Complete blood count (CBC)
• Blood tests to evaluate hemolysis
• Flow cytometry to detect missing protective proteins on blood cells
• Lactate dehydrogenase (LDH) testing
• Reticulocyte count
• Bone marrow evaluation when appropriate

Flow cytometry is considered the standard test for confirming PNH.

Treatment Options

Treatment depends on symptoms, disease severity, and the presence of complications.

Possible treatments include:

• Complement inhibitor therapy
• Blood transfusions for severe anemia
• Iron or folate supplementation when appropriate
• Anticoagulant therapy for selected individuals at risk of blood clots
• Bone marrow transplantation in carefully selected cases
• Supportive care to manage symptoms

Treatment plans are personalized and require ongoing medical supervision.

Monitoring

Regular follow-up helps evaluate disease activity and treatment response.

Monitoring may include:

• Blood counts
• LDH levels
• Kidney function tests
• Assessment for blood clots
• Review of symptoms
• Evaluation of treatment effectiveness

Routine monitoring allows early detection of complications.

Living With PNH

People living with PNH may benefit from:

• Keeping regular hematology appointments
• Taking prescribed medications consistently
• Reporting new symptoms promptly
• Staying physically active within personal limits
• Maintaining a balanced diet
• Receiving recommended vaccinations when appropriate

Individual care plans are based on overall health and disease severity.

When to Seek Immediate Medical Care

Urgent medical attention is recommended if symptoms include:

• Sudden chest pain
• Difficulty breathing
• Severe abdominal pain
• Swelling or pain in an arm or leg
• Sudden weakness or difficulty speaking
• Heavy bleeding
• High fever

These symptoms may indicate serious complications requiring immediate treatment.

Conclusion

Paroxysmal nocturnal hemoglobinuria is a rare blood disorder that can cause chronic hemolysis, anemia, and an increased risk of blood clots. Advances in complement inhibitor therapies have transformed the management of PNH, allowing many individuals to achieve better disease control and improved quality of life.